ニュース
Lonza has launched its new Design2Optimize platform to enhance process development and manufacturing of small molecule APIs.
Sanofi has entered into an agreement to acquire Vigil Neuroscience Inc., a publicly traded clinical-stage biotechnology ...
The BioMed X Institute has launched a new global call for research proposals in collaboration with Boehringer Ingelheim.
Bora Biologics, a contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, is ...
The U.S. Food and Drug Administration (FDA) has granted an expanded interchangeable designation for Celltrion’s YUFLYMA.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する